Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $86,653 - $134,519
-82,527 Reduced 75.18%
27,242 $30,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $86,367 - $196,486
-71,973 Reduced 39.6%
109,769 $148,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $210,059 - $443,459
122,842 Added 208.56%
181,742 $338,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $110,428 - $501,575
-58,120 Reduced 49.67%
58,900 $145,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $2.01 Million - $8.51 Million
-944,827 Reduced 88.98%
117,020 $286,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $6.67 Million - $16.6 Million
1,061,847 New
1,061,847 $8.46 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $5.8 Million - $8.01 Million
-238,435 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $6.22 Million - $9.63 Million
238,435 New
238,435 $8.04 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $2.4 Million - $4.14 Million
-72,698 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $2.84 Million - $4.17 Million
72,698 New
72,698 $3.04 Million
Q1 2019

May 15, 2019

SELL
$10.65 - $25.75 $817,302 - $1.98 Million
-76,742 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $260,678 - $461,113
28,151 Added 57.93%
76,742 $849,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $366,376 - $889,701
48,591 New
48,591 $813,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.